Translated by ChatGPT, edited by Sinocism.com.

Source: Ministry of Commerce of the People’s Republic of China (MOFCOM) | October 9, 2026

Attachment

附件

Trade and Investment Balance

贸易和投资平衡

1. The two sides will continue to explore the possibility of reducing tariffs on certain goods within the framework of World Trade Organization rules.

双方将继续探讨在世贸组织规则框架下，降低部分商品关税的可能性。

2. The two sides will continue to strengthen communication and cooperation under the trade-monitoring mechanism and will make further active use of dialogue mechanisms to enhance mutual understanding.

双方将继续在贸易监测机制项下加强沟通合作，并进一步积极发挥对话机制作用，增进相互理解。

3. Following intensive consultations, the two sides reached an understanding on trade in hybrid vehicles in a manner consistent with World Trade Organization rules.

经密集磋商，双方以符合世贸组织规则的方式就混动汽车贸易达成谅解。

4. The two sides recalled the guidance document on price undertakings in the electric-vehicle anti-subsidy case and will continue the related procedures concerning company price undertakings and the review in that case.

双方忆及电动汽车反补贴案价格承诺指导文件，并将继续电动汽车反补贴案企业价格承诺和复审相关程序。

5. The two sides will continue their dialogue on market access for medical devices. The EU side welcomes the measures China has taken to expand imports of EU medical devices, including holding a procurement matchmaking event during the ninth China International Import Expo.

双方将继续就医疗器械市场准入问题保持对话。欧方欢迎中方扩大进口欧盟医疗器械采取的措施，包括在第九届进博会期间举办采购对接会。

6. Based on risk assessments, China will expedite its work to recognize the regionalization principle for eligible EU member states. The two sides agreed to exchange methods and technologies for disease control and jointly explore ways to lift bluetongue-related restrictions on exports to China from the relevant member states.

中方将在风险评估基础上，加快对符合条件的欧盟相关成员国的区域化原则认可工作。双方同意就疫病管控的方法与技术开展交流，共同探索解除相关成员国蓝舌病输华限制的方法。

7. The two sides agreed to continue technical exchanges on computer reservation systems. They also agreed to hold follow-up consultations on their respective regulatory frameworks for cosmetics and pharmaceuticals, in order to further address existing and emerging market-access issues.